PE20010935A1 - Compuestos antitromboticos - Google Patents

Compuestos antitromboticos

Info

Publication number
PE20010935A1
PE20010935A1 PE2000001308A PE0013082000A PE20010935A1 PE 20010935 A1 PE20010935 A1 PE 20010935A1 PE 2000001308 A PE2000001308 A PE 2000001308A PE 0013082000 A PE0013082000 A PE 0013082000A PE 20010935 A1 PE20010935 A1 PE 20010935A1
Authority
PE
Peru
Prior art keywords
pentasacarido
spacer
refers
antithrombotic compounds
pentascarido
Prior art date
Application number
PE2000001308A
Other languages
English (en)
Spanish (es)
Inventor
Tamara Theodora Maria Geertsen
Boeckel Constant Adriaan Anton Van
Cornelia Maria Tromp
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20010935A1 publication Critical patent/PE20010935A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
PE2000001308A 1999-12-07 2000-12-06 Compuestos antitromboticos PE20010935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204172 1999-12-07

Publications (1)

Publication Number Publication Date
PE20010935A1 true PE20010935A1 (es) 2001-09-20

Family

ID=8240976

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001308A PE20010935A1 (es) 1999-12-07 2000-12-06 Compuestos antitromboticos

Country Status (23)

Country Link
US (1) US6875755B2 (enExample)
EP (1) EP1237897B1 (enExample)
JP (1) JP4820517B2 (enExample)
KR (1) KR100776607B1 (enExample)
CN (1) CN1195767C (enExample)
AR (1) AR026726A1 (enExample)
AU (1) AU781846B2 (enExample)
BR (1) BR0016217A (enExample)
CA (1) CA2393042C (enExample)
CO (1) CO5251449A1 (enExample)
CZ (1) CZ303385B6 (enExample)
HK (1) HK1047593A1 (enExample)
HU (1) HUP0203471A3 (enExample)
IL (2) IL149628A0 (enExample)
NO (1) NO323059B1 (enExample)
NZ (1) NZ519100A (enExample)
PE (1) PE20010935A1 (enExample)
PL (1) PL202840B1 (enExample)
RU (1) RU2266913C2 (enExample)
SK (1) SK287682B6 (enExample)
TW (1) TWI289566B (enExample)
WO (1) WO2001042262A2 (enExample)
ZA (1) ZA200203799B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2806561C (en) * 2001-09-07 2015-12-22 Alchemia Limited Synthetic heparin pentasaccharides
WO2004007468A1 (en) 2002-07-15 2004-01-22 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
CA2499586A1 (en) 2002-10-07 2004-04-22 Merck & Co., Inc. Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors
MXPA05004890A (es) * 2002-11-07 2005-07-22 Merck & Co Inc Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevencion de diabetes.
WO2004064778A2 (en) 2003-01-17 2004-08-05 Merck & Co. Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004069162A2 (en) 2003-01-31 2004-08-19 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US7560455B2 (en) 2003-05-14 2009-07-14 Merck & Co., Inc. 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
AU2004247068A1 (en) 2003-06-06 2004-12-23 Merck & Co., Inc. Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1638950A4 (en) 2003-06-17 2010-06-30 Merck Sharp & Dohme CYCLOHEXYLGLYCIN DERIVATIVES AS DIPEPTIDYLPEPTIDASEINHIBITORS FOR THE TREATMENT OF BZW. PREVENTION OF DIABETES
WO2005011581A2 (en) 2003-07-31 2005-02-10 Merck & Co., Inc. Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
MY145269A (en) * 2005-10-10 2012-01-13 Organon Nv Antithrombotic dual inhibitors comprising a biotin label
WO2011073408A2 (en) 2009-12-18 2011-06-23 Endotis Pharma Pharmaceutical oral dosage form containing a synthetic oligosaccharide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DK0649854T3 (da) * 1993-09-01 2000-07-03 Akzo Nobel Nv Biskonjugater omfattende to saccharider og en spacer
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
RU2225869C2 (ru) * 1998-06-17 2004-03-20 Акцо Нобель Н.В. Антитромботические соединения

Also Published As

Publication number Publication date
IL149628A (en) 2010-04-29
US20030114361A1 (en) 2003-06-19
CO5251449A1 (es) 2003-02-28
ZA200203799B (en) 2003-10-29
JP4820517B2 (ja) 2011-11-24
AU2003801A (en) 2001-06-18
CN1195767C (zh) 2005-04-06
CZ303385B6 (cs) 2012-08-29
EP1237897B1 (en) 2015-01-14
WO2001042262A2 (en) 2001-06-14
NO20022689L (no) 2002-06-06
NO323059B1 (no) 2006-12-27
EP1237897A2 (en) 2002-09-11
RU2266913C2 (ru) 2005-12-27
HUP0203471A3 (en) 2003-03-28
AU781846B2 (en) 2005-06-16
WO2001042262A3 (en) 2001-12-13
HK1047593A1 (zh) 2003-02-28
SK7942002A3 (en) 2002-09-10
PL202840B1 (pl) 2009-07-31
CA2393042A1 (en) 2001-06-14
AR026726A1 (es) 2003-02-26
NO20022689D0 (no) 2002-06-06
IL149628A0 (en) 2002-11-10
KR100776607B1 (ko) 2007-11-16
JP2003520208A (ja) 2003-07-02
BR0016217A (pt) 2002-09-10
CN1407989A (zh) 2003-04-02
TWI289566B (en) 2007-11-11
PL355484A1 (en) 2004-05-04
NZ519100A (en) 2004-09-24
CA2393042C (en) 2011-06-28
US6875755B2 (en) 2005-04-05
KR20020070988A (ko) 2002-09-11
HUP0203471A2 (hu) 2003-02-28
SK287682B6 (sk) 2011-06-06
CZ20021958A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
PE20010935A1 (es) Compuestos antitromboticos
ES2017647B3 (es) Nuevos tioeteres fenolicos como inhibidores de 5-lipoxigenasa.
BRPI9912175A (pt) peptídios de antígeno cd4-cdr2, composição farmacêutica compreendendo os mesmos bem como uso da mesma
BR0007781A (pt) Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf
GT199900022A (es) Compuestos para el tratamiento de la isquemia
BR0114630A (pt) Secretagogos de hormÈnio do crescimento
BR9914167A (pt) Composto, método de tratamento, inibição do crescimento de, ou erradicação de neoplasmas, e de doença de rim policìstico, em um mamìfero em necessidade do mesmo, composição farmacêutica, e processo para preparar o composto
BR9811948A (pt) Secretores de hormÈnio do crescimento
ES2160897T3 (es) Pirazoles como inhibidores de la secretora fosfolipasa a2 humana no pancreatica.
BR0005266A (pt) Compostos para o tratamento de disfução sexual feminina
ES2055159T3 (es) Composiciones que inducen la union entre partes de tejido mineralizado vivo.
ES525692A0 (es) Procedimiento para la obtencion de dihidropirimidinas
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
KR960022506A (ko) 피롤 유도체
AR026063A1 (es) Metodo para la preparacion de 5-carboxiftalida.
EA200000896A1 (ru) S-ЗАМЕЩЕННЫЕ ТИОЛОВЫЕ ЭФИРЫ 11b-БЕНЗАЛЬДОКСИМЭСТРА-4,9-ДИЕНУГОЛЬНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
AR013838A1 (es) Compuestos de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b]benzodiazepina-dihidratos; los dihidratos b,d y e de dicho compuesto y proceso para preparar la forma ii sustancialmente pura de la olanzapina a partir de dichos dihidratos
BR9916504A (pt) Hidroxamatos de sulfonamida
ATE283256T1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
ES2107806T3 (es) Nuevos esteroides.
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
BR9915019A (pt) Derivados de propanolamina ligados com ácido biliar para o tratamento de distúrbios do metabolismo de lipìdeos
BR9909981A (pt) Soluções de mitoxantrona estáveis
ES2038700T3 (es) Procedimiento para la obtencion de alilmercaptoacetil-sidnoniminas.
AR031536A1 (es) Analogos heteroatomo- interrumpidos del acido 15-hidroxieicosatetraenoico, composicion que lo comprende y el uso de los mismos para la manufactura de un medicamento

Legal Events

Date Code Title Description
FG Grant, registration
AE Restoration of lapsed or forfeited application
FG Grant, registration
FD Application declared void or lapsed